Christiana Care Health Services
Trial Pipeline
Abnormal Connectivity Involving the Social Reciprocity Network in Autism and the Impact of Neurostimulation in Mitigating the Abnormalities
NCT06807684
Oxytocin Rest to Reduce Cesarean Delivery
NCT06268431
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
NCT06180811
Work of Breathing in Term Infants
NCT05209269
Work of Breathing and Kangaroo Mother Care
NCT03683316
Utilization of Very Low Calorie Diet in Obese General Surgery Patients
NCT03553849
Mouth Guard Use in the Second Stage of Labor
NCT03520530
Evaluation of the Heparin Binding Protein Levels in Sepsis
NCT02533011
Clinical Assessment and Thickness Changes of the Oblique and Multifidus Muscles
NCT03539211
Foley With Oxytocin Versus Foley no Oxytocin for Induction of Labor
NCT02273115
Comparison of Two Methods of Immunization for Intramuscular Injections
NCT01721083
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721
Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS
NCT01272882
Ultrasound IV Study
NCT01100593
High Fat Diet II on Weight Loss
NCT00525850
Psychosocial Outcomes in Online Cancer Support Groups
NCT00382785
Emergency Ultrasound of the Gallbladder
NCT00388830
Thrombopoietin Levels and Platelet Transfusion in Neonates
NCT00549484
Active Versus Expectant Management of the Third Stage of Labor
NCT00473707
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 2 |
Therapeutic Areas
What the Pipeline for Christiana Care Health Services Shows
According to the ClinicalTrials.gov registry, Christiana Care Health Services is linked to 50 US clinical trials across every stage of research activity. Of those, 34 studies are currently recruiting — about 68% of the sponsor's indexed portfolio — and 16 are already marked complete, representing roughly 32% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Christiana Care Health Services reports 2 late-stage studies (Phase 3 and Phase 4 combined) and 0 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Christiana Care Health Services is Work of Breathing with 2 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.